""Online pharmacies are advertising drugs with only upsides mentioned, contributing to America's culture of overreliance on pharmaceuticals for health," Makary wrote in a JAMA Network Open article focused on how the agency is overdue for a "crackdown on misleading pharmaceutical advertisements.""
""This breach of FDA regulation was most overt earlier this year when Hims & Hers ran a Super Bowl ad highlighting the benefits of glucagon-like peptide-1 drugs without any mention of side effects or disclaimers," Makary wrote."
The FDA identified a Hims & Hers Super Bowl advertisement promoting a compounded version of Novo Nordisk's Wegovy that emphasized benefits of GLP‑1 obesity drugs while omitting side effects and disclaimers. The agency sent hundreds of warning letters to drug companies and online telehealth firms marketing compounded products, signaling increased scrutiny of copycat drug promotions. President Trump's executive order directed agencies to ensure transparency and accuracy in direct‑to‑consumer prescription drug advertising. Telehealth companies argue jurisdiction lies with the FTC, while opponents contend FDA oversight is necessary because advertisements can omit potential harms, creating a regulatory gray area.
Read at Bloomberglaw
Unable to calculate read time
Collection
[
|
...
]